A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT02597049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Parallel-Arm, Double-Blind Study of Efficacy and Safety of Dulaglutide When Added to SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
Study identification
- NCT ID
- NCT02597049
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 424 participants
Conditions and interventions
Conditions
Interventions
- Dulaglutide Drug
- Metformin Drug
- Placebo Drug
- SGLT2 inhibitor Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2015
- Primary completion
- Jan 31, 2017
- Completion
- Jan 31, 2017
- Last update posted
- Jun 16, 2020
2015 – 2017
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Group of Encino | Encino | California | 91436 | — |
| National Research Institute | Huntington Park | California | 90255 | — |
| National Research Institute | Los Angeles | California | 90057 | — |
| New Horizon Research Center | Miami | Florida | 33175 | — |
| Metabolic Research Institute Inc. | West Palm Beach | Florida | 33401 | — |
| Cotton O'Neil Diabetes and Endocrinology Center | Topeka | Kansas | 66606 | — |
| JCMG Clinical Research | Jefferson City | Missouri | 65109 | — |
| Grand Street Medical PC | Brooklyn | New York | 11211 | — |
| Diabetes & Endocrinology Consultants PC | Morehead City | North Carolina | 28557 | — |
| PMG Research of Wilmington, LLC | Wilmington | North Carolina | 28401 | — |
| Dallas Diabetes Endocrine Center | Dallas | Texas | 75230 | — |
| Galenos Research | Dallas | Texas | 75251 | — |
| Endeavor Clinical Trials | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02597049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2020 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02597049 live on ClinicalTrials.gov.